Drug search by name

Brentuximab Intravenous and Hepatotoxicity

Result of checking the interaction of drug Brentuximab Intravenous and disease Hepatotoxicity for safety when used together.

Check result:

Brentuximab Intravenous <> Hepatotoxicity

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

The use of brentuximab vedotin should be avoided in patients with moderate or severe hepatic impairment. Serious cases of hepatotoxicities have occurred in patients receiving this agent. Patients with preexisting liver disease, and those with elevated baseline liver enzymes may be at an increased risk. Monitor liver enzymes and bilirubin. Patients experiencing new, worsening, or recurrent hepatotoxicity may require a delay, change in dose, or discontinuation of therapy.

Brentuximab Intravenous

Generic Name: brentuximab

Brand Name: Adcetris

Synonyms: Brentuximab vedotin, Brentuximab Vedotin

What is Brentuximab Intravenous?